News Bayer files 'safer, greener' MRI contrast agent in US FDA starts its review of Bayer's gadoquatrane, an MRI contrast agent that reduces the amount of gadolinium in medical imaging procedures.
News AI picks up interval breast cancers missed by scans An AI could help to detect aggressive interval breast cancers that are diagnosed in between routine screening appointments, say US researchers.
Oncology Beyond traditional cancer treatment: Can we confront unmet n... Surgery, chemotherapy, radiotherapy, and immunotherapy are designed to kill cancer, but what if we could control cancer?
News UK cancer centre launches AI-powered detection drive The Royal Marsden NHS Foundation Trust has joined forces with two private-sector companies on AI models to detect cancer and guide treatment choices.
News Bayer, Google partner on AI for time-pressed radiologists Bayer has joined forces with Google Cloud to continue development of an artificial intelligence-powered platform to help radiologists diagnose patients quicker and more ef
News Swiss hospital adopts Bayer’s AI platform for radiology A leading Swiss teaching hospital has signed up to use Bayer’s suite of artificial intelligence-powered digital tools for X-ray, MRI, and CT imaging.
News After setback, Rhythm gets good news on Imcivree from FDA Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.